Author: A. Ant, CADC-II, Licensing & Accreditation Expert
New Hampshire Mental Health Inpatient Licensing: Psychiatric Residential Treatment Programs
Round-the-clock psychiatric care in New Hampshire runs through He-P 830, the rule governing Psychiatric Residential Treatment Programs, or PRTPs. It’s a distinct licensing category from the SUD-RTF rule that covers substance use residential care, even though the two populations overlap constantly in practice.
What a PRTP is actually built to do
He-P 830 describes psychiatric residential programs as structured to provide intensive short-term, intermediate, and long-term mental health services to people who have psychiatric disorders or are in an acute phase of their mental illness. That range (short-term crisis stabilization through longer-term residential care) means the rule has to flex across very different lengths of stay, and your program’s actual model needs to match what you’re licensed for.
Chemical restraint is explicitly defined and explicitly restricted
This is one of the more consequential definitions in He-P 830: chemical restraint means any medication prescribed to control a client’s behavior or emotional state without a supporting diagnosis, or for the convenience of staff. That’s not a vague ethical guideline. It’s a defined term inspectors check against actual medication administration records. A PRTP that can’t demonstrate a diagnosis-driven rationale for a psychiatric medication is exposed here regardless of how well everything else is documented.
Assessment and change-of-ownership provisions
He-P 830 requires a documented assessment (an evaluation determining what care and services a client actually needs) as a foundational part of admission, not paperwork completed after treatment has already started. The rule also specifically addresses change of ownership, meaning a shift in who controls an established PRTP triggers its own regulatory requirements rather than being treated as a routine administrative update.
Ketamine and Spravato in a PRTP
An interpretation of He-P 830 as described above, read alongside the Spravato REMS. New Hampshire hasn’t issued ketamine guidance for PRTPs.
He-P 830’s chemical restraint definition is the right place to start. Any medication given to control behavior or emotional state without a supporting diagnosis counts as chemical restraint, and ketamine’s fast effect on agitation and suicidal crisis makes that a live concern. A PRTP adding ketamine or Spravato needs every order tied to a documented diagnosis such as treatment-resistant depression, with the treatment plan showing the reasoning, so the medication record reads as treatment and not restraint.
PRTPs span short-term crisis stabilization through long-term residential care, so the fit varies. Long-term PRTP residents are the better candidates, because a month or more in the program gives staff time to see whether the benefit holds between sessions before anyone commits to an outpatient series. Crisis stabilization beds turn over in days, so a resident who starts there leaves with an appointment already booked with the prescriber who will finish it. Spravato asks less of a PRTP than an IV line does, though the program still registers under the drug’s REMS and staffs a two-hour observation window per dose. Adding either service is a change Health Facilities Administration should hear about in advance.
Where This Fits In
This covers PRTP licensure under He-P 830 specifically. See New Hampshire Behavioral Health Licensing for the full picture.
This content is provided for general informational purposes only and should not be construed as medical, clinical, legal, financial, tax, accounting, insurance, licensing, accreditation, regulatory, billing, employment, or compliance advice. Requirements change often. Consult qualified professionals for guidance specific to your situation.
Working through a change of ownership for a New Hampshire PRTP?
Sources
- NH Admin. Rules He-P 830.01 (Justia): PRTP purpose (checked October 8, 2026)
- NH Admin. Rules He-P 830.03 (Justia): PRTP definitions, including chemical restraint, assessment and change of ownership (checked October 8, 2026)
- NH DHHS: Health Facilities Administration (checked October 8, 2026)
Leave a Reply